Inflammation-related plasma and CSF biomarkers for multiple sclerosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammation-related plasma and CSF biomarkers for multiple sclerosis
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201912839
Publisher
Proceedings of the National Academy of Sciences
Online
2020-05-27
DOI
10.1073/pnas.1912839117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncostatin M, an Underestimated Player in the Central Nervous System
- (2019) Evelien Houben et al. Frontiers in Immunology
- Strong impact on plasma protein profiles by precentrifugation delay but not by repeated freeze-thaw cycles, as analyzed using multiplex proximity extension assays
- (2018) Qiujin Shen et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers
- (2018) Lenka Novakova et al. PLoS One
- Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro
- (2018) Fuyuko Takata et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Multiple sclerosis
- (2018) Massimo Filippi et al. Nature Reviews Disease Primers
- The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis
- (2017) Jan Lycke et al. Expert Review of Clinical Immunology
- Age Related Multiple Sclerosis Severity Score: Disability ranked by age
- (2017) Ali Manouchehrinia et al. Multiple Sclerosis Journal
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- Serum neurofilament is associated with progression of brain atrophy and disability in early MS
- (2017) Jens Kuhle et al. NEUROLOGY
- Age Related Multiple Sclerosis Severity Score: Disability ranked by age
- (2017) Ali Manouchehrinia et al. Multiple Sclerosis Journal
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- Cystatin D (CST5): An ultra-early inflammatory biomarker of traumatic brain injury
- (2017) Lisa J. Hill et al. Scientific Reports
- The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets
- (2016) Reinhard Hohlfeld et al. LANCET NEUROLOGY
- The contemporary spectrum of multiple sclerosis misdiagnosis
- (2016) Andrew J. Solomon et al. NEUROLOGY
- Body fluid biomarkers for multiple sclerosis—the long road to clinical application
- (2015) Charlotte E. Teunissen et al. Nature Reviews Neurology
- Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
- (2014) Erika Assarsson et al. PLoS One
- Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells
- (2014) Felix J. Hartmann et al. Nature Communications
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers
- (2013) Mohsen Khademi et al. PLoS One
- Regional Neural Activation Defines a Gateway for Autoreactive T Cells to Cross the Blood-Brain Barrier
- (2012) Yasunobu Arima et al. CELL
- Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models
- (2012) Lianhua Bai et al. NATURE NEUROSCIENCE
- Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats
- (2012) Milena Z. Adzemovic et al. PLoS One
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
- (2010) Manuel Comabella et al. BRAIN
- Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis
- (2010) Jorge Correale et al. Multiple Sclerosis Journal
- Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
- (2010) Mohsen Khademi et al. Multiple Sclerosis Journal
- MRI criteria for MS in patients with clinically isolated syndromes
- (2010) X. Montalban et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid
- (2009) J. Mellergård et al. Multiple Sclerosis Journal
- C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
- (2009) Andrea Reboldi et al. NATURE IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started